Sabal Trust CO Bristol Myers Squibb CO Transaction History

Sabal Trust CO

$1.68 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $50,653 - $56,638	-875 Reduced 14.82%	5,028 $291,000
Q2 2023 Jul 20, 2023	SELL	$63.71 - $70.74 $17,647 - $19,594	-277 Reduced 4.48%	5,903 $377,000
Q1 2023 Apr 26, 2023	SELL	$65.71 - $74.53 $109,538 - $124,241	-1,667 Reduced 21.24%	6,180 $428,000
Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $8,696 - $10,298	-127 Reduced 1.59%	7,847 $564,000
Q3 2022 Oct 18, 2022	BUY	$0.13 - $76.84 $50 - $30,121	392 Added 5.17%	7,974 $567,000
Q2 2022 Jul 18, 2022	BUY	$72.62 - $79.98 $11,546 - $12,716	159 Added 2.14%	7,582 $584,000
Q1 2022 Apr 14, 2022	SELL	$61.48 - $73.72 $439,213 - $526,655	-7,144 Reduced 49.04%	7,423 $542,000
Q4 2021 Jan 21, 2022	SELL	$53.63 - $62.52 $15.9 Million - $18.5 Million	-295,975 Reduced 95.31%	14,567 $908,000
Q3 2021 Oct 18, 2021	BUY	$59.17 - $69.31 $644,657 - $755,132	10,895 Added 3.64%	310,542 $18.4 Million
Q2 2021 Jul 16, 2021	BUY	$61.91 - $67.42 $784,337 - $854,143	12,669 Added 4.41%	299,647 $20 Million
Q1 2021 Apr 19, 2021	BUY	$59.34 - $66.74 $1.11 Million - $1.25 Million	18,748 Added 6.99%	286,978 $18.1 Million
Q4 2020 Jan 20, 2021	BUY	$57.74 - $65.43 $1.32 Million - $1.5 Million	22,884 Added 9.33%	268,230 $16.6 Million
Q3 2020 Oct 14, 2020	BUY	$57.43 - $63.64 $507,279 - $562,132	8,833 Added 3.73%	245,346 $14.8 Million
Q2 2020 Jul 13, 2020	BUY	$54.82 - $64.09 $12.4 Million - $14.5 Million	226,347 Added 2226.51%	236,513 $13.9 Million
Q1 2020 Apr 14, 2020	SELL	$46.4 - $67.43 $194,880 - $283,206	-4,200 Reduced 29.24%	10,166 $567,000
Q4 2019 Jan 14, 2020	BUY	$49.21 - $64.19 $2,460 - $3,209	50 Added 0.35%	14,366 $922,000
Q3 2019 Oct 15, 2019	BUY	$42.77 - $50.71 $232,711 - $275,913	5,441 Added 61.31%	14,316 $726,000
Q2 2019 Jul 17, 2019	SELL	$44.62 - $49.34 $47,163 - $52,152	-1,057 Reduced 10.64%	8,875 $402,000
Q1 2019 Apr 12, 2019	SELL	$45.12 - $53.8 $85,502 - $101,951	-1,895 Reduced 16.02%	9,932 $474,000
Q4 2018 Feb 01, 2019	BUY	$48.76 - $63.23 $39,251 - $50,900	805 Added 7.3%	11,827 $615,000
Q3 2018 Oct 16, 2018	SELL	$55.19 - $62.25 $416,684 - $469,987	-7,550 Reduced 40.65%	11,022 $685,000
Q2 2018 Jul 16, 2018	SELL	$50.53 - $62.98 $20.7 Million - $25.8 Million	-410,088 Reduced 95.67%	18,572 $1.03 Million
Q1 2018 Apr 16, 2018	BUY	$59.92 - $68.98 $5,932 - $6,829	99 Added 0.02%	428,660 $27.1 Million
Q4 2017 Feb 07, 2018	BUY	$59.94 - $65.35 $396,503 - $432,290	6,615 Added 1.57%	428,561 $26.3 Million
Q3 2017 Oct 17, 2017	BUY	$55.23 - $63.74 $23.3 Million - $26.9 Million	421,946	421,946 $26.9 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabal Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sabal Trust CO with notifications on news.

Account